D. G. Armstrong, A. Boulton, and S. A. Bus, Diabetic Foot Ulcers and Their Recurrence

J. R. Ingelfinger, J. Engl, and . Med, , vol.376, pp.2367-75, 2017.

C. W. Hicks, S. Selvarajah, N. Mathioudakis, R. L. Sherman, K. F. Hines et al., Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs, Ann Vasc Surg, vol.33, pp.149-58, 2016.

K. Al-rubeaan, A. Derwish, M. Ouizi, S. Youssef, A. M. Subhani et al.,

, Diabetic Foot Complications and Their Risk Factors from a Large Retrospective Cohort Study, vol.10, p.124446, 2015.

A. I. Adler, S. Erqou, T. Lima, and A. Robinson, Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitusreview and meta-analysis, Diabetologia, vol.53, issue.5, pp.840-849, 2010.

R. Hasan, B. Firwana, T. Elraiyah, J. P. Domecq, G. Prutsky et al., A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome, J Vasc Surg, vol.63, issue.2, pp.22-28, 2016.

D. J. Margolis, J. Kantor, J. Santanna, B. L. Strom, and J. A. Berlin, Risk Factors for Delayed Healing of Neuropathic Diabetic Foot Ulcers: A Pooled Analysis, Arch Dermatol

, , vol.136, 2019.

A. L. Christman, E. Selvin, D. J. Margolis, G. S. Lazarus, and L. A. Garza, Hemoglobin A1c Predicts Healing Rate in Diabetic Wounds, J Invest Dermatol, vol.131, issue.10, pp.2121-2128, 2011.

M. Ndosi, A. Wright-hughes, S. Brown, M. Backhouse, B. A. Lipsky et al., Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study, Diabet Med, vol.35, issue.1, pp.78-88, 2018.

B. K. Fesseha, C. J. Abularrage, K. F. Hines, R. Sherman, P. Frost et al., Association of Hemoglobin A1c and Wound Healing in Diabetic Foot Ulcers, Diabetes Care, vol.41, issue.7, pp.1478-85, 2018.

L. A. Lavery, D. G. Armstrong, R. P. Wunderlich, M. J. Mohler, C. S. Wendel et al., Risk Factors for Foot Infections in Individuals With Diabetes. Diabetes Care, vol.29, pp.1288-93, 2006.

J. A. Critchley, I. M. Carey, T. Harris, S. Dewilde, F. J. Hosking et al., Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study, Diabetes Care, vol.41, issue.10, pp.2127-2162, 2018.

E. Peters, L. A. Lavery, and D. G. Armstrong, Diabetic lower extremity infection, J Diabetes Complications, vol.19, issue.2, pp.107-119, 2005.

L. Jia, C. N. Parker, T. J. Parker, E. M. Kinnear, P. H. Derhy et al., Breddy JL, Veves A, Boulton AJM. The Prediction of Diabetic Neuropathic Foot Ulceration Using Vibration Perception Thresholds: A prospective study. Diabetes Care, PLoS ONE, vol.12, issue.5, pp.557-60, 1994.

D. G. Armstrong, L. A. Lavery, and L. B. Harkless, Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care, vol.21, pp.855-864, 1998.

L. A. Lavery, D. G. Armstrong, D. P. Murdoch, E. Peters, and B. A. Lipsky, Validation of the Infectious Diseases Society of America's Diabetic Foot Infection Classification System, Clin Infect Dis, vol.44, issue.4, pp.562-567, 2007.

L. Prompers, M. Huijberts, J. Apelqvist, J. E. Piaggesi, A. Bakker et al., High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study, Diabetologia, 2007.

M. Monami, R. Longo, C. M. Desideri, G. Masotti, N. Marchionni et al., The diabetic person beyond a foot ulcer: healing, recurrence, and depressive symptoms, J Am Podiatr Med Assoc, vol.98, issue.2, pp.130-136, 2008.

J. Richard, J. Lavigne, I. Got, A. Hartemann, D. Malgrange et al., Management of patients hospitalized for diabetic foot infection: Results of the French OPIDIA study, Diabetes Metab, vol.37, issue.3, pp.208-223, 2011.

A. Hartemann-heurtier, G. H. Van, J. P. Danan, F. Koskas, S. Jacqueminet et al., Outcome of severe diabetic foot ulcers after standardised management in a specialised unit, Diabetes Metab, vol.28, p.8, 2002.

J. Pearson-stuttard, S. Blundell, T. Harris, D. G. Cook, and J. Critchley, Diabetes and infection: assessing the association with glycaemic control in population-based studies, Lancet Diabetes Endocrinol, vol.4, issue.2, pp.148-58, 2016.

F. Hirashima, R. B. Patel, J. E. Adams, D. J. Bertges, P. W. Callas et al., Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures, Ann Thorac Surg, vol.56, issue.2, pp.352-60, 1999.

B. Rathsman, K. Jensen-urstad, T. Nyström, A. Akturk, J. J. Netten et al., Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study, Diabetologia, vol.57, issue.8, pp.1-8, 2014.

D. G. Armstrong, A. Boulton, and S. A. Bus, Diabetic foot ulcers and their recurrence, N Engl J Med, vol.376, issue.24, pp.2367-2375, 2017.

C. Amadou, A. Carlier, and C. Amouyal, Five-year mortality in patients with diabetic foot ulcer during 2009-2010 was lower than expected, Diabetes Metab, pp.1-6, 2019.

, Microvascular complications and foot care: Standards of Medical Care in Diabetes, Diabetes Care, vol.10, issue.1, pp.105-118, 2018.

H. Gin, R. Baudoin, C. H. Raffaitin, V. Rigalleau, and C. Gonzalez, Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation, Diabetes Metab, vol.37, issue.6, pp.527-532, 2011.

H. Pham, D. G. Armstrong, C. Harvey, L. B. Harkless, J. M. Giurini et al., Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial, Diabetes Care, vol.23, issue.5, pp.606-611, 2000.

C. Amadou, A. Carlier, C. Amouyal, O. Bourron, A. C. Couture et al., Five-year mortality in patients with diabetic foot ulcer during 2009-2010 was lower than expected, Diabetes Metab, 2019.

D. G. Armstrong, A. Boulton, and S. A. Bus, Diabetic foot ulcers and their recurrence, N Engl J Med, vol.376, pp.2367-75, 2017.

H. Gin, V. Rigalleau, L. Baillet, and C. Rabemanantsoa, Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication, Diabetes Metab, vol.28, pp.457-61, 2002.

E. M. Hoffman, N. P. Staff, J. M. Robb, S. Sauver, J. L. Dyck et al., Impairments and comorbidities of polyneuropathy revealed by population-based analyses, Neurology, vol.84, pp.1644-51, 2015.

S. S. Soedamah-muthu, N. Chaturvedi, D. R. Witte, L. K. Stevens, M. Porta et al., Relationship between risk factors and mortality in type 1 diabetic patients in Europe, Diabetes Care, vol.31, pp.1360-1366, 2008.

Y. K. Kim, H. S. Lee, J. J. Ryu, I. Lee, H. Seo et al., Sarcopenia increases the risk for mortality in patients who undergo amputation for diabetic foot, J Foot Ankle Res, vol.11, pp.1-8, 2018.

J. Doupis, T. E. Lyons, S. Wu, C. Gnardellis, T. Dinh et al., Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy, J Clin Endocrinol Metab, vol.94, pp.2157-63, 2009.

V. I. , International Diabetes Federation. IDF Diabetes Atlas, 2019.

S. Fosse-edorh, L. Mandereau-bruno, and C. Piffaretti, Le poids du diabète en France en 2016. Synthèse épidémiologique, vol.8, 2018.

, Available from: www.santepubliquefrance.fr

D. G. Armstrong, A. Boulton, and S. A. Bus, Diabetic Foot Ulcers and Their Recurrence

, New England Journal of Medicine, vol.376, issue.24, pp.2367-75, 2017.

C. W. Hicks, S. Selvarajah, N. Mathioudakis, R. L. Sherman, K. F. Hines et al., Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs. Annals of Vascular Surgery, vol.33, pp.149-58, 2016.

L. A. Lavery, D. G. Armstrong, R. P. Wunderlich, M. J. Mohler, C. S. Wendel et al., Risk Factors for Foot Infections in Individuals With Diabetes. Diabetes Care, vol.29, pp.1288-93, 2006.

E. Peters, L. A. Lavery, and D. G. Armstrong, Diabetic lower extremity infection, Journal of Diabetes and its Complications, vol.19, issue.2, pp.107-119, 2005.

J. A. Critchley, I. M. Carey, T. Harris, S. Dewilde, F. J. Hosking et al., Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study, Diabetes Care, vol.41, issue.10, pp.2127-2162, 2018.

L. Jia, C. N. Parker, T. J. Parker, E. M. Kinnear, P. H. Derhy et al., Incidence and risk factors for developing infection in patients presenting with uninfected diabetic foot ulcers, PLoS One, vol.12, issue.5, 2017.

P. Zhang, J. Lu, Y. Jing, S. Tang, D. Zhu et al., Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Annals of Medicine, vol.49, pp.106-122, 2017.

N. R. Barshes, M. Sigireddi, J. S. Wrobel, A. Mahankali, J. M. Robbins et al., The system of care for the diabetic foot: objectives, outcomes, and opportunities. Diabetic Foot & Ankle, vol.4, p.21847, 2013.

H. Van and G. , Le syndrome du pied diabétique, 2019.

V. R. Driver, M. Fabbi, L. A. Lavery, and G. Gibbons, The costs of diabetic foot: The economic case for the limb salvage team, Journal of Vascular Surgery, vol.52, issue.3, pp.17-22, 2010.

L. Prompers, M. Huijberts, N. Schaper, J. Apelqvist, K. Bakker et al., Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study, Diabetologia, vol.51, issue.10, pp.1826-1860, 2008.

, Référentiel des bonnes pratiques SFD paramédical-Médecine des maladies métaboliques, vol.9, 2015.

S. Tesfaye, N. Chaturvedi, S. E. Eaton, J. D. Ward, C. Manes et al., Vascular risk factors and diabetic neuropathy, New England Journal of Medicine, vol.352, issue.4, pp.341-350, 2005.

D. Selvarajah, D. Kar, K. Khunti, M. J. Davies, A. R. Scott et al., Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention, International Diabetes Federation. Clinical Practice Recommendation on the Diabetic Foot: A guide for health care professionals : International Diabetes Federation, vol.7, pp.136-54, 2017.

L. Prompers, N. Schaper, J. Apelqvist, M. Edmonds, J. E. Mauricio et al., Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study, Available from: www.idf.org 19, vol.51, pp.747-55, 2008.

L. Prompers, M. Huijberts, J. Apelqvist, J. E. Piaggesi, A. Bakker et al., High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study, Diabetologia, 2007.

N. C. Dolan, K. Liu, M. H. Criqui, P. Greenland, J. M. Guralnik et al., Peripheral Artery Disease, Diabetes, and Reduced Lower Extremity Functioning. Diabetes Care, 2002.

L. Potier, A. Khalil, C. Mohammedi, K. Roussel, and R. , IWGDF Guidelines on the Prevention and Management of Diabetic Foot Disease, European Journal of Vascular and Endovascular Surgery, vol.25, issue.1, pp.113-133, 2019.

A. Caselli, H. Pham, J. M. Giurini, D. G. Armstrong, and A. Veves, The Forefoot-to-Rearfoot Plantar Pressure Ratio Is Increased in Severe Diabetic Neuropathy and Can Predict Foot Ulceration. Diabetes Care, vol.25, pp.1066-71, 2002.

G. E. Reiber, L. Vileikyte, E. J. Boyko, M. Del-aguila, D. G. Smith et al., Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care, vol.22, pp.157-62, 1999.

A. Boulton, D. G. Armstrong, R. S. Kirsner, C. E. Attinger, L. A. Lavery et al., Diagnosis and Management of Diabetic Foot Complications. Diabetes, vol.2018, pp.1-20, 2018.

M. Monteiro-soares, E. J. Boyko, J. Ribeiro, I. Ribeiro, and M. Dinis-ribeiro, Predictive factors for diabetic foot ulceration: a systematic review: Predictive Factors for Diabetic Foot Ulceration, Diabetes/Metabolism Research and Reviews, vol.28, issue.7, pp.574-600, 2012.

B. A. Lipsky, J. Aragón-sánchez, M. Diggle, J. Embil, S. Kono et al., IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes, Diabetes/Metabolism Research and Reviews, vol.32, issue.S1, pp.45-74, 2016.

J. Apelqvist, J. Larsson, and C. Agardh, Long-term prognosis for diabetic patients with foot ulcers, Journal of Internal Medicine, vol.233, issue.6, pp.485-91, 1993.

E. Faglia, F. Favales, and A. Morabito, New Ulceration, New Major Amputation, and Survival Rates in Diabetic Subjects Hospitalized for Foot Ulceration From 1990 to 1993: A 6.5-year follow-up. Diabetes Care, vol.24, pp.78-83, 2001.

E. Ghanassia, L. Villon, T. Dit-dieudonné, J. Boegner, C. Avignon et al., Long-Term Outcome and Disability of Diabetic Patients Hospitalized for Diabetic Foot Ulcers. Diabetes Care, vol.31, pp.1288-92, 2008.

P. K. Moulik, R. Mtonga, and G. V. Gill, Amputation and Mortality in New-Onset Diabetic Foot Ulcers Stratified by Etiology. Diabetes Care, vol.26, pp.491-495, 2003.

M. Monteiro-soares, D. Martins-mendes, A. Vaz-carneiro, and M. Dinis-ribeiro, Lowerlimb amputation following foot ulcers in patients with diabetes: classification systems, external validation and comparative analysis: Lower-limb Amputation Risk Prediction, Diabetes/Metabolism Research and Reviews, vol.31, issue.5, pp.515-544, 2015.

P. Valensi, I. Girod, F. Baron, T. Moreau-defarges, and P. Guillon, Quality of life and clinical correlates in patients with diabetic foot ulcers, Diabetes & Metabolism, 2005.

M. Dubský, A. Jirkovská, R. Bem, V. Fejfarová, J. Skibová et al., Risk factors for recurrence of diabetic foot ulcers: prospective follow-up analysis in the Eurodiale subgroup, International Wound Journal, vol.10, issue.5, pp.555-61, 2013.

E. Peters, D. G. Armstrong, and L. A. Lavery, Risk Factors for Recurrent Diabetic Foot Ulcers: Site matters. Diabetes Care, vol.30, pp.2077-2086, 2007.

J. W. Walsh, O. J. Hoffstad, M. O. Sullivan, and D. J. Margolis, Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom, Diabetic Medicine, vol.33, issue.11, pp.1493-1501, 2016.

D. G. Armstrong, J. Wrobel, and J. M. Robbins, Guest Editorial: are diabetes-related wounds and amputations worse than cancer?, International Wound Journal, vol.4, issue.4, pp.286-293, 2007.

C. Amadou, A. Carlier, C. Amouyal, O. Bourron, A. C. Couture et al., Five-year mortality in patients with diabetic foot ulcer during 2009-2010 was lower than expected, Diabetes & Metabolism, 2019.

H. Van, G. Amouyal, C. Bourron, and O. , Outcome of diabetic foot ulcer management in a French multidisciplinary foot center: one year healing, amputation and mortality rate, J Wound Care, vol.41, issue.1, pp.26-50, 2007.

B. R. Shah and J. E. Hux, Quantifying the Risk of Infectious Diseases for People With Diabetes. Diabetes Care, vol.26, pp.510-513, 2003.

J. L. Harding, S. R. Benoit, E. W. Gregg, M. E. Pavkov, and L. Perreault, Trends in Rates of Infections Requiring Hospitalization Among Adults With Versus Without Diabetes in the, Diabetes Care, 2000.

M. Ndosi, A. Wright-hughes, S. Brown, M. Backhouse, B. A. Lipsky et al., Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study, Diabetic Medicine, vol.35, issue.1, pp.78-88, 2018.

L. A. Lavery, D. G. Armstrong, D. P. Murdoch, E. Peters, and B. A. Lipsky, Validation of the Infectious Diseases Society of America's Diabetic Foot Infection Classification System, Clinical Infectious Diseases, vol.44, issue.4, pp.562-567, 2007.

M. Mutluoglu, A. K. Sivrioglu, M. Eroglu, G. Uzun, V. Turhan et al., The implications of the presence of osteomyelitis on outcomes of infected diabetic foot wounds, Scandinavian Journal of Infectious Diseases, vol.45, issue.7, pp.497-503, 2013.

L. A. Lavery, E. Peters, D. G. Armstrong, C. S. Wendel, D. P. Murdoch et al., Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Research and Clinical Practice, vol.83, pp.347-52, 2009.

C. L. Ramanujam, D. Han, and T. Zgonis, Medical Imaging and Laboratory Analysis of Diagnostic Accuracy in 107 Consecutive Hospitalized Patients With Diabetic Foot Osteomyelitis and Partial Foot Amputations, Foot & Ankle Specialist, vol.11, issue.5, pp.433-476, 2018.

C. Lauri, M. Tamminga, A. Glaudemans, J. Orozco, L. E. Erba et al., Detection of Osteomyelitis in the Diabetic Foot by Imaging Techniques: A Systematic Review and Meta-analysis Comparing MRI, White Blood Cell Scintigraphy, and FDG-PET. Diabetes Care, vol.40, pp.1111-1131, 2017.

K. Al-rubeaan, A. Derwish, M. Ouizi, S. Youssef, A. M. Subhani et al.,

J. Pearson-stuttard, S. Blundell, T. Harris, D. G. Cook, and J. Critchley, Diabetes and infection: assessing the association with glycaemic control in population-based studies, Diabetic Foot Complications and Their Risk Factors from a Large Retrospective Cohort Study, vol.10, pp.148-58, 2015.

A. I. Adler, S. Erqou, T. Lima, and A. Robinson, Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitusreview and meta-analysis, Diabetologia, vol.53, issue.5, pp.840-849, 2010.

R. Hasan, B. Firwana, T. Elraiyah, J. P. Domecq, G. Prutsky et al., A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome, Journal of Vascular Surgery, vol.63, issue.2, pp.22-28, 2016.

D. J. Margolis, J. Kantor, J. Santanna, B. L. Strom, and J. A. Berlin, Risk Factors for Delayed Healing of Neuropathic Diabetic Foot Ulcers: A Pooled Analysis. Archives of Dermatology, vol.136, 2000.

A. L. Christman, E. Selvin, D. J. Margolis, G. S. Lazarus, and L. A. Garza, Hemoglobin A1c Predicts Healing Rate in Diabetic Wounds, Journal of Investigative Dermatology, vol.131, issue.10, pp.2121-2128, 2011.

B. K. Fesseha, C. J. Abularrage, K. F. Hines, R. Sherman, P. Frost et al., Association of Hemoglobin A1c and Wound Healing in Diabetic Foot Ulcers, Diabetes Care, vol.41, issue.7, pp.1478-85, 2018.

M. J. Young, J. L. Breddy, A. Veves, and A. Boulton, The Prediction of Diabetic Neuropathic Foot Ulceration Using Vibration Perception Thresholds: A prospective study. Diabetes Care, vol.17, pp.557-60, 1994.

D. G. Armstrong, L. A. Lavery, and L. B. Harkless, Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care, vol.21, pp.855-864, 1998.

M. Monami, R. Longo, C. M. Desideri, G. Masotti, N. Marchionni et al., The diabetic person beyond a foot ulcer: healing, recurrence, and depressive symptoms, J Am Podiatr Med Assoc, vol.98, issue.2, pp.130-136, 2008.

J. Richard, J. Lavigne, I. Got, A. Hartemann, D. Malgrange et al., Management of patients hospitalized for diabetic foot infection: Results of the French OPIDIA study, Diabetes & Metabolism, vol.37, issue.3, pp.208-223, 2011.

A. Hartemann-heurtier, G. H. Van, J. P. Danan, F. Koskas, S. Jacqueminet et al., Outcome of severe diabetic foot ulcers after standardised management in a specialised unit, Diabetes Metab, vol.28, p.8, 2002.

F. Hirashima, R. B. Patel, J. E. Adams, D. J. Bertges, P. W. Callas et al., Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. The Annals of Thoracic Surgery, Journal of Vascular Surgery, vol.56, issue.2, pp.352-60, 1999.

B. Rathsman, K. Jensen-urstad, and T. Nyström, Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study, Diabetologia, vol.57, issue.8, pp.1703-1713, 2014.

A. Mor, O. M. Dekkers, J. S. Nielsen, H. Beck-nielsen, H. T. Sørensen et al., Impact of Glycemic Control on Risk of Infections in Patients With Type 2 Diabetes: A Population-Based Cohort Study, American Journal of Epidemiology, vol.186, issue.2, pp.227-263, 2017.

, Adverse Events and Their Association With Treatment Regimens in the Diabetes Control and Complications Trial. Diabetes Care, vol.18, pp.1415-1442, 1995.

A. Akturk, J. J. Netten, R. Scheer, M. Vermeer, and J. G. Baal, Ulcer-free survival days and ulcer healing in patients with diabetic foot ulcers: A prospective cohort study, International Wound Journal, 2019.

A. Simoneau, L. Blanco, F. Domenge, K. Mohammedi, N. Foussard et al., Ulcer-free survival days and ulcer healing in patients with diabetic foot ulcers: A prospective cohort study, International Wound Journal, 2019.

A. Simoneau, N. Foussard, L. Blanco, F. Domenge, M. Monlun et al., Amadou C et al. Five-year mortality in patients with diabetic foot ulcer during 2009-2010 was lower than expected, Diabetes & Metabolism, 2019.

, RESUMÉ Introduction Un mauvais contrôle glycémique favorise les infections chez les sujets diabétiques, mais cela n'a pas été clairement établi pour les infections de plaie de pieds

, L'objectif de notre étude était d'évaluer le contrôle glycémique initial, estimé par l'HbA1c selon la présence ou non d'une infection

, Méthode Nous avons comparé les caractéristiques et le devenir des patients diabétiques hospitalisés pour plaie de pieds entre 2011 à 2014, selon la présence ou non d'une infection. L'infection était définie par la présence d'au moins un signe clinique parmi : purulence, douleur, oedème

, Résultats Cent quarante-trois patients ont été hospitalisés pour plaie de pieds. Il s'agissait en majorité d'hommes (72,9%), âgés de 64±11 ans, pp.20-33

, Au cours du suivi, en médiane de 26 mois (10-54), 94 sujets ont eu une récurrence de la plaie (65,7%) et 15 sont décédés (11,7%), La majorité des plaies étaient uniques (67,8%), situées au niveau des orteils (56,3%)

, Quatre-vingt-dix patients étaient infectés, dont 54 présentaient une infection ostéo-articulaire (37,8%)

, que ceux ne présentant pas d'infection. Il y avait également plus de revascularisations et d'amputations chez les patients infectés que chez ceux non infectés, respectivement 38,9% vs 13,2% et 36,7% vs 1,9% (p<0,001). Les patients infectés avaient une hémoglobine glyquée (HbA1c) plus élevée : 8,8±1,9% vs 8,1±1,8% (p<0,05), même après ajustement sur l'âge, le sexe et la présence d, Les patients infectés avaient une durée initiale d'hospitalisation, un temps de cicatrisation et un nombre de ré-hospitalisations, deux fois plus importants (p<0,01)

, Conclusion L'infection est un élément clé du mauvais pronostic des plaies de pieds diabétiques

, Au moment d'être admise à exercer la Médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Admise dans l'intimité des personnes, je tairai les secrets qui me seront confiés. Reçue à l'intérieur des maisons, je respecterai les secrets des

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

. Titre, Introduction : Un mauvais contrôle glycémique favorise les infections chez les sujets diabétiques, mais cela n'a pas été clairement établi pour les infections de plaie de pieds. L'objectif de notre étude était d'évaluer le contrôle glycémique initial, estimé par l'HbA1c selon la présence ou non d'une infection, chez des patients hospitalisés pour plaie de pieds, Étude descriptive des patients diabétiques hospitalisés pour plaie de pieds au CHU de Bordeaux : lien infection-contrôle glycémique et devenir Résumé, 2011.

, Résultats : Cent quarante-trois patients ont été hospitalisés pour plaie de pieds. Il s'agissait en majorité d'hommes (72,9%), âgés de 64±11 ans, atteints de diabète de type 2 (78,8%) depuis 20±13 ans. La majorité des plaies étaient uniques (67,8%), situées au niveau des orteils (56,3%). La durée médiane de la plaie avant l'admission était de 38 jours (14-90), L'infection était définie par la présence d'au moins un signe clinique parmi : purulence, douleur, oedème, chaleur et/ou induration

, Les patients infectés avaient une durée initiale d'hospitalisation, un temps de cicatrisation et un nombre de réhospitalisations, deux fois plus importants (p<0,01), que ceux ne présentant pas d'infection. Il y avait également plus de revascularisations et d'amputations chez les patients infectés que chez ceux non infectés, respectivement 38,9% vs 13,2% et 36,7% vs 1,9% (p<0,001), Conclusion : L'infection est un élément clé du mauvais pronostic des plaies de pieds diabétiques

. Mots-clés, Our study aimed to search whether baseline HbA1c differed according to the presence of infection in subjects hospitalized for DFU. Methods: We compared the characteristics and outcomes of patients who were admitted in our ward from 2011 to 2014 for a DFU, according to the presence of infection, based on their clinical characteristics: purulence, erythema, pain, tenderness, warmth and/or induration. Results: One hundred and forty-three subjects were admitted for a DFU. They were mainly men (72.9%), with a mean age of 64±11 years, mainly Type 2 (78.8%) with a mean duration of diabetes of 20±13 years. Most ulcers were unique (67.8%), located on the toes (56.3%) or metatarsal heads (25.9%), their duration before admission was 38 days (14-90), Contrôle glycémique, Infection Title: People hospitalized for diabetic foot ulcer: is a poor glycemic control associated with local infection? Abstract: Introduction: Poor glycemic control favors infections in diabetic subjects, but whether hyperglycaemia favors diabetic foot infections that critically complicate Diabetic Foot Ulcer (DFU) remains to be ascertained, vol.17, pp.9-31